|
Orthologous residues
|
|
AML1 (human): S397‑p, AML1 iso2 (human): S397‑p, AML1 iso8 (human): S424‑p, AML1 (mouse): S396‑p, AML1 (rat): S395‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
immunoprecipitation, mutation of modification site
|
|
Relevant cell lines - cell types - tissues:
293T (epithelial)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
human
|
|
Enzymes shown to modify site in vitro:
|
|
|
|
Upstream Regulation
|
|
Treatments, proteins and their effect on site modification:
|
|
Treatments
|
Referenced Treatments
|
Manipulated Protein
|
Referenced Protein
|
Effect
|
Notes
|
|
roscovitine
|
|
|
|
decrease
|
|
|
U0126
|
|
|
|
no change compared to control
|
|
|
LY294002
|
|
|
|
no change compared to control
|
|
|
PP2
|
|
|
|
no change compared to control
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation
|
|
Effect of modification (process):
cell growth, altered
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
HDAC1 (human)
|
|
Disrupts
|
|
|
co-immunoprecipitation
|
|
HDAC3 (human)
|
|
Disrupts
|
|
|
co-immunoprecipitation
|
|
|
Comments:
increases marrow progenitor proliferation
|